Does Dr. EMILY ANDREWS-WILKINSON have financial conflicts of interest?

Dr. EMILY ANDREWS-WILKINSON (NP) has received a total of $435 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $435 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. EMILY ANDREWS-WILKINSON?

According to CMS Open Payments data, Dr. EMILY ANDREWS-WILKINSON received funding from ABBOTT LABORATORIES ($260), AVERITAS PHARMA ($119), and NOVO NORDISK ($56).

Does Dr. EMILY ANDREWS-WILKINSON receive research grants or speaking fees?

Dr. EMILY ANDREWS-WILKINSON has received $435 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. EMILY ANDREWS-WILKINSON

NPReal-Time Hydrated

Specialty: Nurse Practitioner, Family

Practice Location: BROOKHAVEN, MS 39601

NPI Number: 1306884259

LIFETIME INDUSTRY VALUE

$435

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ANDREWS-WILKINSON is a verified Nurse Practitioner, Family practitioner based in BROOKHAVEN, MS.

Between 2021 and 2024, Dr. ANDREWS-WILKINSON had an overall industry promotional and research financial footprint of $435 as recorded in the federal CMS Open Payments database.

$435 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ANDREWS-WILKINSON's primary funding source is ABBOTT LABORATORIES, which accounts for $260 (representing 59.8% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ABBOTT LABORATORIES

Rank 1

$260

59.8%

AVERITAS PHARMA

Rank 2

$119

27.3%

NOVO NORDISK

Rank 3

$56

12.9%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.